insights_auto
Nega BOT tushdi 20,00%?
Batafsil oʻrganishchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
0,0080 A$
arrow_downward
-20,00%(-0,0020) 1K
20-noy, 16:10:07 (GMT+11) · AUD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoBOT tikeri uchun statistika yaratilmoqda...
Ochish
0,01 A$
Yuqori
0,01 A$
Past
0,01 A$
Bozor kapitali
22,10 mln
Oʻrtacha hajm
11,07 mln
Hajmi
8,60 mln
52 haftalik eng yuqori
0,15 A$
52 haftalik eng past
0,01 A$
Aksiya boʻyicha daromad
-0,03 A$
Muomaladagi aksiyalar
2,76 mlrd
Xodimlar soni
11
Ochish
0,01 A$
Yuqori
0,01 A$
Past
0,01 A$
Bozor kapitali
22,10 mln
Oʻrtacha hajm
11,07 mln
Hajmi
8,60 mln
52 haftalik eng yuqori
0,15 A$
52 haftalik eng past
0,01 A$
Aksiya boʻyicha daromad
-0,03 A$
Muomaladagi aksiyalar
2,76 mlrd
Xodimlar soni
11
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Barron's
·
34 daqiqa oldin
S&P 500 Skid Enters Seventh Day as Dow Nears Correction
ChartMill
·
1 soat oldin
S&P 500 Premarket Movers Friday: Gainers and Losers
Coinpaper
·
26 daqiqa oldin
S&P 500 Price Prediction: S&P 500 Falls 2.3% Below 200-Day Average
Reuters
·
58 daqiqa oldin
SocGen sees S&P 500 ending 2027 at 8,500 on AI, earnings support
Profil
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Botanix Pharmaceuticals Ltd haqida